Medscape9h
AstraZeneca Sues Generic Drugmakers, Claims Cancer Drug Patent Violations
AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...
Orally Disintegrating Tablet Market Size, Growth & Forecats By 2033
The global orally disintegrating tablet market size was valued at USD 14.76 billion in 2024 and is projected to grow from USD 16.33 billion in 2025 to USD 28.88 billion by 2033, exhibiting a CAGR of 7 ...
ET Now on MSN22h
Upcoming Q3 Results 2025 This Week: Tata Power, Tata Chemicals, ITC, LIC, Swiggy, Airtel among 781 companies
Divi's Laboratories, Religare Enterprises Ltd, Tata Chemicals, Asian Paints, One Mobikwik , Tata Power Co. Ltd, Titan, ...
India's Alembic Pharma posts lower Q3 profit on weak domestic demand
Indian drugmaker Alembic Pharmaceuticals reported a lower third-quarter profit on Monday, weighed down by weak local sales of ...
India's Gland Pharma reports higher Q3 profit as expenses drop
Indian generic injectables maker Gland Pharma reported a 7% rise in third-quarter profit on Monday, as lower expenses helped mitigate the impact from production issues at its French unit Cenexi. The ...